Skip to main content
. 2011 Jun 3;11:217. doi: 10.1186/1471-2407-11-217

Figure 2.

Figure 2

2a strong, mainly membaneous ECAD expression; 2b absent ECAD expression in another tumour; 2c negative control.

HHS Vulnerability Disclosure